Dupilumab for bullous pemphigoid: Umbrella review of systematic reviews and meta-analyses

By afschroeder • December 16, 2025

Thapa M, Green B, Kasperkiewicz M. Dupilumab for bullous pemphigoid: Umbrella review of systematic reviews and meta-analyses. JAAD Int. 2025 Oct 18;24:172-176. doi: 10.1016/j.jdin.2025.10.004. PMID: 41393351; PMCID: PMC12701699.

Tags: autoantibody, autoimmune blistering disease, bullous pemphigoid, Dermatology, DGSOM Student, Dupilumab, immunobullous disease, Publications, umbrella review

UTX coordinates TCF1 and STAT3 to control progenitor CD8+ T cell fate in autoimmune diabetes

Chen HC, Bang MF, Wang HH, Shpargel KB, Kohn LA, Sailer D, Zhang S, McCarthy EC, Seyedsadr M, Stevens S, Pham CLH, Zhou Z, Yin[...]

A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition

Johnsen NA, Carlisle R, Baghoomian W, Pierce JL, Nguyen MO. A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified[...]

A rare case of dystrophic calcinosis cutis in an infant

Yan MJ, Shen A, Galamgam J, Hogeling M, Cheng C. A rare case of dystrophic calcinosis cutis in an infant. JAAD Case Rep. 2025 Oct[...]